SPDR® Portfolio Small Cap ETFMost RecentCompany & Industry OverviewsTaking Stock of Arrowhead Pharmaceuticals’ Financial PerformanceIn 2017, Arrowhead Pharmaceuticals (ARWR) generated revenue of $31.4 million compared to $158,000 in 2016. This increase was attributable to the upfront payments Arrowhead received from Amgen.
Company & Industry OverviewsTaking Stock of Arrowhead Pharmaceuticals’ Financial PerformanceIn 2017, Arrowhead Pharmaceuticals (ARWR) generated revenue of $31.4 million compared to $158,000 in 2016. This increase was attributable to the upfront payments Arrowhead received from Amgen.
